Apr 23
Boehringer Ingelheim Expands Investment in Computational Innovation with New AI Accelerator in UK’s Knowledge Quarter - AI Insider
★★★★★
significance 2/5
Boehringer Ingelheim is expanding its investment in computational innovation by establishing a new AI accelerator in the UK's Knowledge Quarter. This move aims to bolster the company's capabilities in drug discovery and digital health through advanced computing.
Why it matters
Pharma giants are increasingly embedding specialized AI infrastructure directly into research hubs to accelerate proprietary drug discovery pipelines.
Tags
#biotech #ai accelerator #drug discovery #uk #innovationRelated coverage
- The News InternationalGoogle’s new Pentagon deal: A turning point for AI safety - The News International
- AnthropicAnthropic Sydney office
- 404 MediaUniversity Professors Disturbed to Find Their Lectures Chopped Up and Turned Into AI Slop
- The Verge AICanonical lays out a plan for AI in Ubuntu Linux
- Ars Technica AIOpenAI ends its exclusive partnership with Microsoft